Trileptal (oxcarbazepine) is an anti-seizure drug sometimes taken off-label for bipolar disorder. Learn more about how it ...

And many patients who wind up with the label of bipolar disorder are initially misdiagnosed with unipolar depression. Misdiagnosed patients like Ola often look back on years of worsening symptoms and ...

MBABANE – It was reported last year that there is a company that supplied medical drugs for public use, which the Ministry of Health later recalled.

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

One of the well known symptoms of clinical depression is episodes of pervasive sadness. But you might not know that there are ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...

The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.